SSIs offer risks, not benefits during pregnancy, study says

11/2/2012 | Medscape (free registration)

Taking selective serotonin reuptake inhibitors while pregnant raises a woman's risk of miscarriage, preterm birth and neonatal complications, researchers from Beth Israel Deaconess Medical Center reported. They said there isn't strong data showing benefits, either for mothers or infants, and advised women to discuss use of the medications with their health care practitioner.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Commercial Health Insurance Strategist__Job #52-14
American Academy of Family Physicians
Leawood, KS
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Corporate Regulatory Lawyer EMEA (f/m)
W. L. Gore & Associates GmbH
Putzbrunn (near Munich)